欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/H/4330/001
药品名称
Orlistat-ratiopharm 60 mg Hartkapseln
活性成分
Orlistat 60.0 mg
剂型
Capsule, hard
上市许可持有人
ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Portugal (PT)
Czechia (CZ)
Abra
Belgium (BE)
许可日期
2011/06/27
最近更新日期
2024/11/05
药物ATC编码
A08AB01 orlistat
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Labelling
|
common_final_lab_DE4330_V030
Date of last change:2024/09/06
Final Product Information
|
common_final_pl_4330_V024
Date of last change:2024/09/06
Final PL
|
common_final_pl_DE4330_V030
Date of last change:2024/09/06
Final Product Information
|
common_final_spc_4330_V024
Date of last change:2024/09/06
Final SPC
|
common_final_spc_DE4330_V030
Date of last change:2024/09/06
PubAR
|
PAR _ Orlistat 123ratio PL_H_0161_001_DC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase